Congratulations! BiOptic’s core products have successfully registered and listed in FDA!
2023-02-22
BiOptic has recently registered and listed the core products and related consumables in the USA FDA Class I category. Items including Qsep Series Bio-Fragment Analyzers, Qampmini Thermal Cycler and multiple cartridges ,etc. In the future, the above mentioned core products can be sold as medical equipment in the United States, which will expand our business scope in the US market.
Pittcon is a dynamic, transnational conference and exposition on laboratory science, a venue for presenting the latest advances in analytical research and scientific instrumentation, and a platform for continuing education and science-enhancing opportunity.
Congratulations! BiOptic has won“The 25th Rising Star Award”
2022-11-17
BiOptic has won“The 25th Rising Star Award”, which is awarded by the Ministry of Economic Affairs. We are so honored that BiOptic could stands out from all Bio-industry companies in Taiwan and be the only Bio-company of the 16 winning companies from various industries. The award ceremony was held on the 16th of November, and Dr. Ming-Jhy Hsu, Chief R&D Director, representing BiOptic to receive this award.
Welcome to our booth. This time, you will see the whole Qsep1 series. The world's smallest capillary electrophoresis instrument, including Qsep1-Lite, the entry-level model, Qsep1, the standard model, and Qsep1-Plus, the advanced version.
BiOptic hits a new high in revenue in the first 10-month of 2022
2022-11-11
The world's largest medical tradeshow, MEDICA, in Dusseldorf Germany will be held from November 14th to 17th. BiOptic will participate in the exhibition for the first time after the COVID-19 epidemic. Chairman Eric Tsai said that the company has actively expanded the European market in recent years and the penetration rate continues to increase.
BiOptic has signed memorandum of cooperation with the school of medicine, Chang Gung University
2022-10-28
The school of medicine in Chang Gung University and BiOptic signed a memorandum of cooperation on the morning of October 24th. Starting from the summer vacation of 2023, master and doctoral students of the school's biotechnology industry program can enter the company for a 6-week summer internship program
